Literature DB >> 23812496

Lower limb lymphedema in gynecological cancer survivors--effect on daily life functioning.

Gail Dunberger1, Helene Lindquist, Ann-Charlotte Waldenström, Tommy Nyberg, Gunnar Steineck, Elisabeth Åvall-Lundqvist.   

Abstract

PURPOSE: Lower limb lymphedema (LLL) is a common condition after pelvic cancer treatment but few studies have evaluated its effect on the quality of life and its consequences on daily life activities among gynecological cancer survivors.
METHODS: We identified a cohort of 789 eligible women, treated with pelvic radiotherapy alone or as part of combined treatment of gynecological cancer, from 1991 to 2003 at two departments of gynecological oncology in Sweden. As a preparatory study, we conducted in-depth interviews with gynecological cancer survivors and constructed a study-specific questionnaire which we validated face-to-face. The questionnaire covered physical symptoms originating in the pelvis, demographic, psychological, and quality of life factors. In relation to the lymph system, 19 questions were asked.
RESULTS: Six hundred sixteen (78 %) gynecological cancer survivors answered the questionnaire and participated in the study. Thirty-six percent (218/606) of the cancer survivors reported LLL. Overall quality of life was significantly lower among cancer survivors with LLL. They were also less satisfied with their sleep, more worried about recurrence of cancer, and more likely to interpret symptoms from the body as recurrence. Cancer survivors reported that LLL kept them from physical activity (45 %) and house work (29 %) and affected their ability to partake in social activities (27 %) or to meet friends (20 %).
CONCLUSION: Lower limb lymphedema has a negative impact on quality of life among gynecological cancer survivors, affecting sleep and daily life activities, yet only a few seek professional help.

Entities:  

Mesh:

Year:  2013        PMID: 23812496     DOI: 10.1007/s00520-013-1879-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  29 in total

Review 1.  Quality of life of women with lower-limb lymphedema following gynecological cancer.

Authors:  Anna Finnane; Sandra C Hayes; Andreas Obermair; Monika Janda
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-06       Impact factor: 2.217

2.  Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls.

Authors:  K Bergmark; E Avall-Lundqvist; P W Dickman; L Henningsohn; G Steineck
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

3.  Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer.

Authors:  Jin Hwi Kim; Ji Hyang Choi; Eun Young Ki; Sung Jong Lee; Joo Hee Yoon; Keun Ho Lee; Tae Chul Park; Jong Sup Park; Seog Nyeon Bae; Soo Young Hur
Journal:  Int J Gynecol Cancer       Date:  2012-05       Impact factor: 3.437

4.  Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

Authors:  Eva Johansson; Gunnar Steineck; Lars Holmberg; Jan-Erik Johansson; Tommy Nyberg; Mirja Ruutu; Anna Bill-Axelson
Journal:  Lancet Oncol       Date:  2011-08-05       Impact factor: 41.316

5.  Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors.

Authors:  Gail Dunberger; Helena Lind; Gunnar Steineck; Ann-Charlotte Waldenström; Tommy Nyberg; Massoud al-Abany; Ullakarin Nyberg; Elisabeth Avall-Lundqvist
Journal:  Int J Gynecol Cancer       Date:  2010-04       Impact factor: 3.437

6.  Lymphedema after breast or gynecological cancer: use and effectiveness of mainstream and complementary therapies.

Authors:  Anna Finnane; Yuan Liu; Diana Battistutta; Monika Janda; Sandra C Hayes
Journal:  J Altern Complement Med       Date:  2011-09       Impact factor: 2.579

Review 7.  Physical therapies for reducing and controlling lymphoedema of the limbs.

Authors:  C Badger; N Preston; K Seers; P Mortimer
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

8.  The experience of lower limb lymphedema for women after treatment for gynecologic cancer.

Authors:  Mary Ryan; M Colleen Stainton; Carmel Jaconelli; Sally Watts; Patricia MacKenzie; Tamar Mansberg
Journal:  Oncol Nurs Forum       Date:  2003 May-Jun       Impact factor: 2.172

9.  Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema.

Authors:  A Pyszel; K Malyszczak; K Pyszel; R Andrzejak; A Szuba
Journal:  Lymphology       Date:  2006-12       Impact factor: 1.286

10.  Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls.

Authors:  Gail Dunberger; Helena Lind; Gunnar Steineck; Ann-Charlotte Waldenström; Tommy Nyberg; Massoud Al-Abany; Ullakarin Nyberg; Elisabeth Vall-Lundqvist
Journal:  Eur J Cancer       Date:  2009-11-18       Impact factor: 9.162

View more
  24 in total

1.  Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.

Authors:  Imari Deura; Muneaki Shimada; Keiko Hirashita; Maki Sugimura; Seiya Sato; Shinya Sato; Tetsuro Oishi; Hiroaki Itamochi; Tasuku Harada; Junzo Kigawa
Journal:  Int J Clin Oncol       Date:  2014-07-04       Impact factor: 3.402

2.  A Comparison of the Quality of Life in Patients With Primary and Secondary Lower Limb Lymphedema: A Mixed-Methods Study.

Authors:  Deonni P Stolldorf; Mary S Dietrich; Sheila H Ridner
Journal:  West J Nurs Res       Date:  2016-05-05       Impact factor: 1.967

3.  Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.

Authors:  K D Cromwell; Y J Chiang; J Armer; P P Heppner; K Mungovan; M I Ross; J E Gershenwald; J E Lee; R E Royal; A Lucci; J N Cormier
Journal:  Eur J Cancer Care (Engl)       Date:  2015-03-24       Impact factor: 2.520

Review 4.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

5.  Utility of sentinel lymph node biopsy for solitary dermal melanomas.

Authors:  Yinin Hu; Puja Shah; George J Stukenborg; Craig L Slingluff
Journal:  J Surg Oncol       Date:  2015-02-24       Impact factor: 3.454

Review 6.  Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Muneaki Shimada; Shinya Sato; Etsuko Miyagi; Akiko Tozawa-Ono; Nao Suzuki; Masaki Fujimura; Yoichi Aoki; Satoru Sagae; Toru Sugiyama
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

7.  Symptom Frequency, Intensity, and Distress in Patients with Lower Limb Lymphedema.

Authors:  Deonni P Stolldorf; Mary S Dietrich; Sheila H Ridner
Journal:  Lymphat Res Biol       Date:  2016-01-29       Impact factor: 2.589

8.  Gastroepiploic vascularized lymph node transfer for the treatment of extremity lymphedema: comparison between middle and distal inset.

Authors:  Oscar J Manrique; Samyd Said Bustos; Trishul Kapoor; Jason Lin; Pedro Ciudad; Antonio J Forte; Gabriel Del Corral; Maria Mani; Michele Maruccia; Andre Terzic
Journal:  Gland Surg       Date:  2020-04

9.  From Bench to Bedside: The Role of a Multidisciplinary Approach to Treating Patients with Lymphedema.

Authors:  Rachel Lentz; Christina Shin; Zoe Bloom; Kimiko Yamada; Young-Kwon Hong; Alex K Wong; Ketan Patel
Journal:  Lymphat Res Biol       Date:  2021-02-05       Impact factor: 2.589

10.  Cohort profile: an observational longitudinal data collection of health aspects in a cohort of female cancer survivors with a history of pelvic radiotherapy-a population-based cohort in the western region of Sweden.

Authors:  Linda Åkeflo; Gail Dunberger; Eva Elmerstig; Viktor Skokic; Gunnar Steineck; Karin Bergmark
Journal:  BMJ Open       Date:  2021-07-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.